BRCA1 and breast carcinoma: At present, the most frequent indications for bilateral risk-reducing mastectomy are high risk histology (such as a typical ductal or lobular hyperplasia and lobular carcinoma in situ), strong family history and positive mutation in the BRCA1 or BRCA2 genes [16].